Kothari Fermentation & Biochem Ltd (KFBL) — shareholding pattern, promoter holding, financials and share price
About Kothari Fermentation & Biochem Ltd (KFBL)
Kothari Fermentation & Biochem Ltd operates in the Other Food Products industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as KFBL and on the BSE under scrip code 507474. Its ISIN is INE991B01010.
Incorporated in 1990, Kothari Fermentation and Biochem Ltd focuses exclusively on the manufacture of yeast and related products. [1]
Kothari Fermentation and Biochem Ltd (KFBL) is a manufacturer of yeast and its derivatives, including compressed yeast and yeast extract paste. The company's products cater to the food, biotechnology, and pharmaceutical sectors.
KFBL's yeast products are marketed under the 'Sunrise' brand, serving industries that utilize molasses for alcohol production and offering yeast extracts as premium ingredients.
Listed peers in Other Food Products: Gujarat Peanut & Agri Products Ltd, Team24 Consumer Products Ltd, Oceanic Foods Ltd, Artemis ADR Marketplace Ltd, Saboo Sodium Chloro Ltd.
Valuation & Returns
10 Jul 2026At ₹43.73 a share on 10 Jul 2026, Kothari Fermentation & Biochem Ltd (KFBL) was valued at a price-to-book of 1.16x on a book value of ₹37.71 per share as of Mar 2025. Solomo computes return on equity of -5.85% and return on capital employed of 0.24% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- Industry P/E
- 45.12x
- P/B
- 1.16x
- EPS (TTM)
- ₹-2.21
- Book value / share
- ₹37.71
- ROE
- -5.85%
- ROCE
- 0.24%
- ROA
- -2.59%
- Debt / equity
- 0.77x
- Dividend yield
- 0%
- EBITDA margin
- 6.46%
- 52-week range
- ₹30.2 – ₹69.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Kothari Fermentation & Biochem Ltd (KFBL) reported revenue of ₹112 crore, net profit of ₹-3 crore and earnings per share of ₹-1.99. That compares with revenue of ₹114 crore and net profit of ₹1 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹32.47 crore and net profit ₹1.27 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 97 | 110 | 109 | 114 | 112 |
| Net profit (₹ cr) | 0 | 0 | -5 | 1 | -3 |
| EPS (₹) | 0.21 | 0.13 | -3.27 | 0.54 | -1.99 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 4.45% | 3.38% | 5.59% | 4.91% |
| Profit growth | -8.98% | -36.21% | 38.37% | 116.50% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 68.87% of Kothari Fermentation & Biochem Ltd (KFBL) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹66 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: DHEERAJ KUMAR LOHIA 1.36%, HUF 1.21%, ASHISH CHUGH . 1.18%, MAHENDRA GIRDHARILAL 1.05%, SATYA PRAKASH MITTAL 1.01%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 68.87% | - | - | 0% | 31.13% |
| Mar 2026 | 68.87% | - | 0% | 0% | 31.13% |
| Dec 2025 | 68.87% | - | - | 0% | 31.13% |
| Sep 2025 | 68.87% | - | - | 0% | 31.13% |
| Jun 2025 | 70.14% | - | - | 0% | 29.86% |
| Mar 2025 | 71.66% | - | - | 0% | 28.34% |
| Dec 2024 | 72.36% | - | - | 0% | 27.64% |
| Sep 2024 | 74.91% | - | - | 0% | 25.09% |